The impact of age and chronic kidney disease on secondary prevention post-primary percutaneous coronary intervention

D. Zachariah (Lead / Corresponding author), R. Brown, P. Kanagala, A. Bashir, M. Mohan, P. Callan, R. Rajendra, A. L. Clark, I. Squire, M. Gunning, C. C. Lang, P. R. Kalra

    Research output: Contribution to journalArticle

    4 Citations (Scopus)

    Abstract

    Objective: Historical data suggest elderly patients and those with chronic kidney disease (CKD) receive suboptimal secondary prevention following myocardial infarction (MI). We evaluated the impact of age and CKD on secondary prevention following primary percutaneous coronary intervention (PPCI) in a contemporary unselected cohort.

    Design: We studied 1169 consecutive patients from five UK centres receiving PPCI for ST elevation MI, with use of evidence-based secondary prevention at discharge assessed by age (<60, 60–75 and >75 years) and estimated glomerular filtration rate (eGFR). Follow-up prescribing practice was assessed in 567 patients.

    Results: One-fifth of patients receiving PPCI were >75 years. This group received fewer secondary prevention drugs at discharge compared to younger patients (P < 0.01 for ß-blockers, angiotensin-converting enzyme (ACE) inhibitors/angiotensin receptor blockers (ARB) and statins). By 6 weeks post-PPCI, there was a small drop-off in evidence-based therapy; ß-blocker and statin use in those >75 years fell from 90% to 86% and 96% to 93%, respectively. CKD (eGFR<60 ml/min/1.73 m2) was seen in 17.6%. Declining renal function was associated with age, female sex and lower use of ACE inhibitor/ARB. At discharge 83.5% of patients with eGFR<60 ml/min/1.73 m2 were receiving ACE inhibitors/ARB, dropping to 77.5% at 6 weeks (compared with 95% and 92%, respectively, in patients with eGFR >60 ml/min/1.73 m2).

    Conclusions: The uptake of secondary prevention medication is high following PPCI in the UK, even in the elderly and in those with renal dysfunction. A focus on strategies to improve up-titration and continuation of drugs following discharge is required.
    Original languageEnglish
    Pages (from-to)185-192
    JournalQJM : an International Journal of Medicine
    Volume107
    Issue number3
    Early online date5 Nov 2013
    DOIs
    Publication statusPublished - Mar 2014

    Fingerprint Dive into the research topics of 'The impact of age and chronic kidney disease on secondary prevention post-primary percutaneous coronary intervention'. Together they form a unique fingerprint.

  • Cite this

    Zachariah, D., Brown, R., Kanagala, P., Bashir, A., Mohan, M., Callan, P., Rajendra, R., Clark, A. L., Squire, I., Gunning, M., Lang, C. C., & Kalra, P. R. (2014). The impact of age and chronic kidney disease on secondary prevention post-primary percutaneous coronary intervention. QJM : an International Journal of Medicine, 107(3), 185-192. https://doi.org/10.1093/qjmed/hct222